Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male and have been diagnosed with prostate cancer
- People who have had at least 2 prescription records for either enzalutamide or darolutamide during a specific time period identified by the trial
- People who had a diagnosis of either hormone-sensitive prostate cancer that has spread (mHSPC) or non-metastatic castration-resistant prostate cancer (nmCRPC) on or before the start date set by the trial (confirm with trial site)
- People who were aged 55 or older at the time of that start date
Who may not be able to join:
- People who have prior use of certain prostate cancer medicines (abiraterone, apalutamide, enzalutamide, or darolutamide) before the trial start date, or who show evidence of castration-resistant prostate cancer before the trial start date — this applies specifically to those with hormone-sensitive prostate cancer that has spread (confirm with trial site)
- People with non-metastatic castration-resistant prostate cancer who show evidence that the cancer had already spread to other parts of the body within the first 30 days after the trial start date
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18888422937
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence proportion and incidence rate (per 100 person-years) of 3-point major cardiovascular event (MACE); Estimation of the association of risk factors with 3-point MACE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.